Drugs / SHR-2002
Trials 2
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT05198817 | Feb 2022 → Jan 2023 | cancer | Suzhou Suncadia Biopharmaceuticals Co., Ltd. | Unknown | No outcome recorded |
| Phase 1 | NCT05082545 | Nov 2021 → Jul 2023 | cancer | Atridia Pty Ltd. | Completed | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | SHR-2002 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05082545 ↗ |